Pages that link to "Q54682177"
Jump to navigation
Jump to search
The following pages link to Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-β mRNA (Q54682177):
Displaying 31 items.
- TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis (Q30483018) (← links)
- Recent developments in drug therapy for multiple sclerosis (Q33639891) (← links)
- Effective induction of protective systemic immunity with nasally administered vaccines adjuvanted with IL-1. (Q33665793) (← links)
- Oral tolerance: mechanisms and therapeutic applications. (Q33683196) (← links)
- Dominant regulation: a common mechanism of monoclonal antibody induced tolerance? (Q33723083) (← links)
- T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis (Q33723154) (← links)
- Manipulation of TGF-beta to control autoimmune and chronic inflammatory diseases (Q33804148) (← links)
- Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine (Q34106906) (← links)
- Modulating phenotype and cytokine production of leucocytic retinal infiltrate in experimental autoimmune uveoretinitis following intranasal tolerance induction with retinal antigens (Q35309706) (← links)
- Antigen‐specific blocking of CD4‐Specific immunological synapse formation using BPI and current therapies for autoimmune diseases (Q35637379) (← links)
- Suppression of EAE and prevention of blood-brain barrier breakdown after vaccination with novel bifunctional peptide inhibitor (Q35718387) (← links)
- Immune modulating peptides for the treatment and suppression of multiple sclerosis (Q36151968) (← links)
- Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease (Q36327367) (← links)
- Antigen-specific therapies in multiple sclerosis. (Q36327373) (← links)
- Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease (Q36906673) (← links)
- Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary (Q37313911) (← links)
- Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis (Q37364480) (← links)
- mTOR regulates neuroprotective effect of immunized CD4 Foxp3 T cells in optic nerve ischemia (Q37439191) (← links)
- Emerging immunopharmacological targets in multiple sclerosis (Q37559970) (← links)
- Role of cytokines as mediators and regulators of microglial activity in inflammatory demyelination of the CNS. (Q37735773) (← links)
- The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. (Q38186206) (← links)
- Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats (Q46511868) (← links)
- Modulating the immune system through nanotechnology. (Q48630939) (← links)
- IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat. (Q48910020) (← links)
- Embelin suppresses dendritic cell functions and limits autoimmune encephalomyelitis through the TGF-β/β-catenin and STAT3 signaling pathways. (Q54563660) (← links)
- Infectious tolerance. (Q55068093) (← links)
- Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases (Q63433111) (← links)
- Adherent dendritic cells expressing high levels of interleukin-10 and low levels of interleukin-12 induce antigen-specific tolerance to experimental autoimmune encephalomyelitis (Q73271020) (← links)
- Preventive administration of Mycobacterium tuberculosis 10-kDa heat shock protein (hsp10) suppresses adjuvant arthritis in Lewis rats (Q77969613) (← links)
- Intranasal delivery of FSD-C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis (Q87716863) (← links)
- Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis (Q90049708) (← links)